Genpact Ltd (G) Shares Surge 6.7% -- What GF Score of 88 Tells I
Genpact Ltd (G) shares surged 6.7%, and the company is currently valued as 26.9% undervalued according to GuruFocus's GF Value™. Despite a strong GF Score™ of 88/100, driven by high profitability and growth, the stock exhibits weak momentum and a concerning trend of insider selling without any buying activity, which investors should consider carefully.
Genpact Limited (G) stock price, news, quote and history
This page provides a comprehensive overview of Genpact Limited (G) stock, including its current price, recent news, historical data, and financial statistics. It features interactive charts, key performance indicators, and allows for comparison with similar companies in the industry. The stock closed at $33.85, showing a slight decrease of 0.12% at the close of trading.
Genpact Limited (G) latest stock news and headlines – Yahoo Finance
This Yahoo Finance page provides the latest news and headlines for Genpact Limited (G), including recent articles on AI, stock performance, corporate awards, and new appointments. It also displays the current stock price, after-hours trading, and performance overview comparing Genpact's returns against the S&P 500 benchmark.
Genpact (NYSE: G) details pay and limits for its departing CFO
Genpact Limited filed an amendment detailing the separation terms for its former Chief Financial Officer, Michael Weiner. He will receive a $683,500 severance, $45,327 for health coverage, and a prorated 2027 bonus of $168,534. These payments are conditional on his compliance with non-compete, non-solicitation, confidentiality, and non-disparagement covenants for one year post-separation.
Genpact (NYSE: G) insider plans $368K stock sale
An insider at Genpact Limited (NYSE: G), Balkrishan Kalra, has filed a Rule 144 notice to sell 10,000 common shares, valued at approximately $367,904. The planned sale is scheduled for September 14, 2026, on the NYSE and involves performance shares acquired on January 10, 2025. Morgan Stanley Smith Barney LLC will handle the transaction.
Genpact (NYSE: G) CEO sells 10,000 shares, keeps 501,114
Genpact LTD's President and CEO, Balkrishan Kalra, sold 10,000 Common Shares on September 14, 2026, at a weighted average price of $36.79 per share, totaling approximately $368,000. Following this transaction, Kalra directly holds 501,114 Common Shares. The sale was an open market or private transaction and was not conducted under a Rule 10b5-1 trading plan.
Genpact (NYSE: G) plans Delaware switch—what changes for shareholders?
Genpact Limited (G) has filed an amended Form S-4 to register 180,845,599 shares of common stock for a proposed one-for-one share conversion as it plans to redomicile from Bermuda to Delaware. This move, expected around March 1, 2027, aims to simplify the corporate structure, align with its U.S.-based leadership, and achieve cost efficiencies. While the company's business, assets, liabilities, and management will remain unchanged, the domestication will alter shareholder rights under Delaware law and bring complex U.S. federal income tax considerations, including potential PFIC-related rules.
Genpact CEO Balkrishan Kalra Sells 10,000 Shares at $36.79 Each
Balkrishan Kalra, President and CEO of Genpact Ltd (NYSE:G), sold 10,000 common shares on September 14, 2026, at a weighted average price of $36.79 per share. After the open-market sale, Kalra directly retains 501,114 common shares of the company. The transaction details were reported in a Form 4 filed with the SEC on September 16, 2026.
Genpact CFO Sumita Pandit Awarded 76,713 RSUs in September 2026 Under 2017 Incentive Plan
Genpact CFO Sumita Pandit was awarded 76,713 restricted share units (RSUs) on September 9, 2026, under the company's 2017 Omnibus Incentive Compensation Plan. These RSUs were granted at no cost and will vest in three equal annual installments starting September 9, 2027, contingent on her continued employment. Following this transaction, Pandit beneficially owns 76,713 common shares of Genpact Ltd.
CFO at Genpact (NYSE: G) gets 76,713-share stock grant
Genpact's CFO, Sumita Pandit, received a grant of 76,713 restricted share units (RSUs) on September 9, 2026, as part of the company's 2017 Omnibus Incentive Compensation Plan. These RSUs will vest in three equal tranches annually starting September 9, 2027, provided her continued service. The transaction, reported via Form 4, indicates no purchase price for the RSUs and no Rule 10b5-1 trading plan was associated.
Genpact Launches Agentic Record-to-Report Suite to Improve Finance Productivity, Controls, and Close Predictability
Genpact has launched its Agentic Record-to-Report (R2R) Suite, an AI-powered solution designed to enhance finance teams' efficiency, control, and predictability during the financial close cycle. This suite uses agentic AI to address journal entries, reconciliations, and intercompany processes, aiming to reduce peak financial close effort by up to 40% and resolve intercompany breaks in real-time. The solution, which builds on Genpact's Agentic Operations strategy, allows finance professionals to focus on strategic insights rather than reactive tasks.
Genpact (G) Senior Vice President Anil Nanduru Sells 6,191 Shares
Genpact's Senior Vice President Anil Nanduru sold 6,191 shares for approximately $229,252, contributing to a trend of 16 insider sells and no insider buys at the company over the past year. Despite this, Genpact appears modestly undervalued based on its GF Value and has seen accumulation by institutional investors. Investors are advised to consider both the insider selling and the favorable valuation metrics, along with guru buying activity, in their due diligence.
Genpact SVP Anil Nanduru Executes Sale of 6,191 Shares at $37.03 Each
Anil Nanduru, Senior Vice President at Genpact Ltd (NYSE:G), sold 6,191 common shares on August 19, 2026, at a price of $37.03 per share. This transaction, an open-market sale, was disclosed in a Form 4 filing dated August 20, 2026. Following the sale, Nanduru directly owns 70,253 common shares of Genpact Ltd.
Genpact (G) SVP sells 6,191 shares in August stock trade
Genpact Senior Vice President Anil Nanduru sold 6,191 Common Shares of Genpact (G) on August 19, 2026, at a price of $37.03 per share, totaling approximately $229,271. Following this transaction, Nanduru directly holds 70,253 Common Shares of the company. The sale was reported via a Form 4 filing and was an open market or private transaction not executed under a Rule 10b5-1 plan.
Genpact (NYSE: G) executive lines up new $229K stock sale
Genpact Limited officer Anil Nanduru plans to sell 6,191 shares of common stock, valued at $229,221.78, through Morgan Stanley Smith Barney LLC. This proposed sale follows two recent insider sales by Nanduru in August 2026, totaling over 29,000 shares for approximately $987,500. The transaction is being filed under Rule 144 of the SEC, which governs the resale of restricted and control securities.
Genpact (NYSE: G) SVP Sameer Dewan sells 14,972 shares
Genpact (NYSE: G) Senior Vice President Sameer Dewan sold a total of 14,972 common shares on August 14, 2026, through open market or private transactions. The shares were sold in two blocks, one at $34.10 per share and another at a weighted average price of $34.10, with individual sales ranging from $34.10 to $34.11. This insider activity resulted in a total transaction value of approximately $511,000.
Genpact Named as One of the World's Most Sustainable Companies by TIME for Second Consecutive Year
Genpact (NYSE: G) has been recognized for the second consecutive year as one of TIME magazine's World's Most Sustainable Companies 2026. This acknowledgment highlights Genpact's commitment to responsible innovation, financial performance, transparent sustainability reporting, and environmental and social stewardship. The ranking, compiled by TIME and Statista Inc., assessed over 5,800 companies based on more than 20 key performance indicators.
Royal Bank of Canada Sells 86,932 Shares of Genpact Limited $G
Royal Bank of Canada reduced its stake in Genpact Limited (NYSE:G) by 50.1%, selling 86,932 shares but retaining 86,500 shares valued at approximately $3.22 million. Institutional investors now own 96.03% of Genpact, and analysts maintain a "Hold" rating with an average price target of $39.33. Genpact reported strong quarterly earnings of $1.00 EPS and $1.34 billion in revenue, along with declaring a quarterly dividend of $0.1875.
Genpact Ltd (G) CFO Michael Weiner Sells 5,900 Shares
Genpact Ltd's CFO, Michael Weiner, sold 5,900 shares of the company's stock for approximately $200,836, bringing his direct ownership to 176,027 shares. This sale is part of a larger trend of insider selling at Genpact, with 14 insider sells and zero buys over the past year. Despite the insider selling, GuruFocus valuation metrics suggest that Genpact Ltd is "Modestly Undervalued" with a GF Value of $46.74 compared to its trading price of $34.04.
Genpact (NYSE:G) Delivers Dividend Quality with a Sustainable Payout
Genpact (NYSE:G) has been identified as a quality dividend stock due to its sustainable payout, as highlighted by ChartMill's "Best Dividend" screen. The company boasts a modest but well-supported dividend yield of 2.18%, a low payout ratio of 20.88%, and a consistent dividend growth history of over 10 years without cuts. Its strong profitability and solid financial health further reinforce its ability to maintain and grow its dividends, making it an attractive option for income-focused investors.
Genpact (NYSE: G) CFO sells 5,900 shares, retains 176,027 holding
Genpact LTD's Chief Financial Officer, Michael Hal Weiner, sold 5,900 Common Shares on August 13, 2026, at a price of $34.04 per share. Following this transaction, Weiner directly holds 176,027 Common Shares, including 1,591 shares acquired through the Genpact Employee Stock Purchase Plan (ESPP). The sale was reported as an open-market or private transaction and was not affirmed as being under a Rule 10b5-1 trading plan.
Company G (G) insider plans NYSE sale of 14,972 shares via Morgan Stanley
An insider at Company G (G) has filed a Form 144 to sell 14,972 common shares on the NYSE through Morgan Stanley Smith Barney LLC. The aggregate market value of these shares is approximately $510,558.52, with the planned sale date set for August 14, 2026. The shares originated from employee stock purchase plans and performance/restricted stock grants between 2021 and 2026.
HUSSMAN STRATEGIC MARKET CYCLE FUND's Genpact Ltd(G) Holding History
This article details HUSSMAN STRATEGIC MARKET CYCLE FUND's historical holdings in Genpact Ltd (G). As of March 31, 2026, the fund holds no shares of Genpact, having bought and sold 80,000 shares each over time. The fund's estimated gain from its Genpact holdings is $134,450.00, representing a 4.25% return.
Genpact (G) Senior Vice President reports sale of 29,095 common shares
Genpact (G) Senior Vice President Nanduru Anil sold a total of 29,095 common shares in two open-market transactions on August 11 and August 12, 2026. The sales were made at weighted average prices of $33.96 and $33.92 per share, respectively, and were not conducted under a Rule 10b5-1 trading plan. After these transactions, Nanduru Anil holds 76,444 common shares directly.
Genpact LTD (G): AQR Capital discloses 5.07% beneficial stake in 8.6M shares
AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a 5.07% beneficial ownership stake in Genpact LTD, totaling 8,601,538 common shares as of June 30, 2026. This Schedule 13G/A filing indicates shared voting power over 8,394,453 shares and shared dispositive power over all 8,601,538 shares, with no sole voting or dispositive authority reported. The disclosure highlights AQR's significant institutional holding in Genpact's equity.
HFS Places Genpact in Top Tier for AI-Led Anti-Money Laundering
Genpact (NYSE: G) has been recognized by HFS Research as a Leader in its 2026 HFS Horizons: Financial Crime Compliance in Financial Services report, placing it in the highest tier, Horizon 3. The recognition highlights Genpact's AI-led automation, deep anti-money laundering (AML) expertise, and platform-led FCC architecture, including solutions like riskCanvas and Banking Analyst Suite. HFS praised Genpact's process-first approach and technology-led workflows for modernizing AML operations and enabling financial institutions to focus on real threats rather than manual processes.
US$42.18 - That's What Analysts Think Genpact Limited (NYSE:G) Is Worth After These Results
Genpact Limited (NYSE:G) shares dropped 5.1% following its latest quarterly results, despite reporting revenues of US$1.3 billion and a statutory profit of US$0.86 per share, slightly exceeding analyst expectations. Analysts have reconfirmed their revenue and earnings forecasts for 2026, with revenues projected at US$5.44 billion and EPS at US$3.55, indicating no major changes in expectations. Despite this, the consensus price target for Genpact rose by 7.4% to US$42.18, suggesting analysts believe the intrinsic value of the business is likely to improve.
Company G (NYSE: G) insider Anil Nanduru files to sell 11,852 shares
Anil Nanduru, an insider at Company G (NYSE: G), has filed a Form 144 to sell up to 11,852 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services. The proposed sale includes Performance Shares from January 2025 and Restricted Stock from January 2026. This filing also discloses that Nanduru previously sold 17,243 common shares on August 11, 2026, for approximately $585,568.83.
US$42.18 - That's What Analysts Think Genpact Limited (NYSE:G) Is Worth After These Results
Genpact Limited's shares dropped 5.1% after its latest quarterly results, despite revenue meeting expectations and statutory profit per share slightly exceeding forecasts. Analysts have maintained their revenue and EPS predictions for 2026, with the consensus price target increasing by 7.4% to US$42.18, suggesting improved intrinsic value expectations. The company is expected to accelerate its revenue growth to 7.2% annually, aligning with the broader industry's growth rate.
G (G) plans NYSE sale of 17,243 common shares via Morgan Stanley
G (Genpact LTD) has filed a Form 144 notice indicating a proposed sale of 17,243 common shares on the NYSE through Morgan Stanley Smith Barney LLC, with a planned sale date of August 11, 2026. The filing also reports prior planned sales, including 11,050 restricted stock shares and 6,193 performance shares. The aggregate market value of the common shares to be sold is reported as $585,568.83.
How Investors May Respond To Genpact (G) Earnings Beat, Strong Guidance and Ongoing Buybacks
Genpact (G) reported strong Q2 2026 results with higher sales and net income, alongside updated guidance for Q3 and the full year. The company also continued its share repurchase program, buying back 1.6 million shares for $50 million, emphasizing its strategy of returning capital to shareholders while expanding its Advanced Technology Solutions. This performance reinforces Genpact's investment narrative, focusing on its pivot to higher-value technology solutions amidst a cautious demand backdrop.
Genpact (NYSE: G) boosts buybacks as operating cash flow tightens
Genpact Limited reported strong Q2 2026 results with increased net revenues and net income, alongside a higher diluted EPS. Despite a decrease in operating cash flow due to increased accounts receivable, the company significantly reduced its long-term debt by repaying its 1.750% 2021 Senior Notes. Genpact also continued its share repurchase program and increased its quarterly dividend, demonstrating a commitment to shareholder returns even with tighter operating cash flow.
Genpact Limited 2026 Q2 - Results - Earnings Call Presentation (NYSE:G)
Genpact Limited has published its Q2 2026 earnings call presentation, detailing its financial results for the quarter. The company reported an EPS of $1.00, beating estimates by $0.03, and revenue of $1.34 billion, surpassing expectations by $11.07 million with a 7.10% year-over-year increase. This article provides access to the slide deck presented during the earnings call.
Genpact Ltd (G) Stock News Today
This article provides an update on Genpact Ltd (G) stock, noting its current trading price, market cap, and P/E TTM. It highlights the availability of news, earnings, analyst ratings, and key developments on the platform, and indicates that more news is expected soon. The stock closed down 5.09% on the previous day.
GUIDANCE: (G) Genpact Limited Expects Q3 Revenue Range $1.37B - $1.38B
Genpact Limited expects its third-quarter revenue to fall between $1.37 billion and $1.38 billion. This guidance provides key financial insights for investors monitoring the company's performance.
Genpact LTD 2026: Revenue $1.34B, EPS $0.86— 10-Q Summary
Genpact LTD reported strong second-quarter 2026 results, with net revenues reaching $1.34 billion, a 7.1% increase year-over-year, and diluted EPS of $0.86, up 14.7%. This growth was primarily driven by a strategic shift towards advanced technology solutions, which saw a 24% rise, and strong demand in the Consumer & Healthcare and High Tech sectors. The company also improved its gross margin to 36.5%, despite increased SG&A spending to support new partnerships and sales capabilities.
Genpact Limited (G) stock price, news, quote and history
This article provides a detailed overview of Genpact Limited (G) stock, including its current price, performance metrics, key events, and financial data. It also outlines the company's services across Financial Services, Consumer and Healthcare, and High Tech and Manufacturing segments, and includes analyst insights and comparisons with similar companies in the Information Technology Services industry.
GUIDANCE: (G) Genpact Limited Expects Q3 Adjusted EPS Range $1.04 - $1.05
Genpact Limited (G) has provided its adjusted earnings per share (EPS) guidance for the third quarter, expecting it to be in the range of $1.04 to $1.05. This financial forecast offers insight into the company's anticipated performance for the upcoming quarter.
Genpact Reports Q2 2026: Revenue $1.343B, Advanced Technology Solutions up 24%, Adj. diluted EPS $1.00
Genpact announced its second-quarter 2026 financial results, reporting net revenue of $1.343 billion, a 7.1% year-over-year increase, and adjusted diluted earnings per share of $1.00, up 13.6% year-over-year. The company's Advanced Technology Solutions segment saw significant growth of 24.1%, contributing 27% to total net revenues. Consequently, Genpact raised its full-year guidance for Advanced Technology Solutions growth to at least 25% and adjusted diluted EPS growth to at least 12% for 2026.
Genpact (NYSE: G) releases Q2 2026 results via furnished press note
Genpact Limited (NYSE: G) has reported its financial results for the three months ended June 30, 2026, through a press release issued on August 6, 2026. This information was furnished to the SEC via an 8-K filing and includes non-GAAP financial measures with reconciliations to GAAP figures. The company specifies that these results are furnished, not filed, and should only be incorporated by reference where explicitly stated in future securities filings.
Genpact Limited (NYSE:G) Receives Consensus Rating of "Hold" from Analysts
Eight analysts have issued a consensus "Hold" rating for Genpact Limited (NYSE:G), with six recommending hold and two recommending buy. The average 12-month price target is $40.25, though several firms recently lowered their targets. Genpact reported strong quarterly earnings of $0.98 per share on $1.30 billion in revenue and declared a quarterly dividend of $0.1875 per share, indicating a 2.1% yield.
Genpact Reports Second Quarter 2026 Results
Genpact (NYSE: G) announced strong financial results for the second quarter ended June 30, 2026, driven by a 24% year-over-year growth in Advanced Technology Solutions net revenue. The company reported net revenues of $1.343 billion, a 7.1% increase, and diluted EPS of $0.86, up 14.7%. Genpact also raised its adjusted diluted EPS growth guidance for the full year 2026 to at least 12%.
Edgestream Partners L.P. Acquires 102,309 Shares of Genpact Limited $G
Edgestream Partners L.P. significantly increased its stake in Genpact Limited (NYSE:G) by 862.8% in the first quarter, purchasing 102,309 additional shares to bring its total holding to 114,167 shares valued at $4.25 million. Other institutional investors also adjusted their positions in Genpact, which currently has a consensus "Hold" rating from analysts with an average price target of $40.25. Genpact reported strong quarterly financials with $1.30 billion in revenue and $0.98 EPS, and declared a quarterly dividend of $0.1875.
Genpact Ltd (G) Risk Assessment: Volatility, Financial Risk & Investment Risk
This article provides a risk assessment for Genpact Ltd (G), highlighting its current risk score, beta value, and various volatility and financial metrics. Genpact's risk assessment score is 8.62, ranking 26th in its industry, and its beta of 0.59 suggests lower volatility compared to the S&P 500. The report details daily returns, Sharpe Ratios, maximum drawdowns, and liquidity measures to give a comprehensive overview of the company's risk profile.
Vanguard Portfolio Management (G) discloses 10.4M-share Genpact Ltd position
Vanguard Portfolio Management LLC has disclosed a 10.4 million-share position in Genpact Ltd, representing a 6.14% ownership stake as of June 30, 2026. The filing indicates Vanguard has sole voting power over 116,538 shares and sole dispositive power over all 10,420,948 shares. This position is held across Vanguard funds and managed accounts, with no single other person having an interest exceeding 5% of the class.
Genpact Ltd (G) Financial Health: Profitability & Balance Sheet Analysis
Genpact Ltd (G) currently holds a robust financial score of 7.53 out of 10, ranking 63rd in its industry for financial health. The company reported a quarterly revenue of $1.30 billion, marking a 6.68% year-over-year increase, and a net profit increase of 13.10% year-over-year. Despite strong financial health, its operating efficiency is noted as average.
Genpact Ltd Today's Market Trends | G Stock Real-Time Quotes, Trading Strategies & Related Analysis | TradingKey
Genpact Ltd (G) closed at 36.720 USD, up 6.10%, with a market cap of 6.22B. The company is considered fairly valued with strong fundamentals and high growth potential, though technicals don't fully support the current trend. Analysts have a "Buy" rating with a target price of 39.67.
Genpact Ltd (G) Institutional Confidence
Genpact Ltd (G) has an institutional confidence score of 10.00, ranking 1st in the Professional & Commercial Services industry. Its institutional shareholding proportion is 106.06%, a slight decrease from the previous quarter. Bill Nygren | OAKMX is the largest institutional shareholder, holding 2.30M shares.
Genpact Ltd (G) Valuation: PE, PB & Fair Value Analysis
This article provides a valuation analysis of Genpact Ltd (G), noting its current valuation score of 9.68, ranking 8th in its industry. It highlights the company's P/E ratio of 9.75, which is significantly lower than its recent high but above its recent low. The article indicates that other key valuation metrics like P/B, P/S, and P/CF have not yet been disclosed by the company.
Genpact Ltd (G) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides a historical overview of dividend payouts for Genpact Ltd (G), detailing interim and final cash dividends distributed over the past five years. It lists key dates including record, payment, and ex-dividend dates, along with the gross dividend amounts. The company has distributed a total of $380.80 million in dividends over this period.
